Differential telomerase expression in idiopathic pulmonary fibrosis and non-small cell lung cancer

Oncology Reports

Volumn 30, Issue 6, 2013, Pages 2617-2624

  Antoniou, K M ^a   Samara, K D ^a   Lasithiotaki, I ^a   Margaritopoulos, G A ^a   Soufla, G ^a   Lambiri, I ^a   Giannarakis, I ^a   Drositis, I ^a   Spandidos, D A ^a   Siafakas, N M ^a  

^a UNIVERSITY OF CRETE   (Greece)

Author keywords

Bronchoalveolar lavage fluid; Carcinogenesis; Fibrogenesis; Lung tissue; Telomerase

Indexed keywords

MESSENGER RNA; TELOMERASE REVERSE TRANSCRIPTASE; TRANSFORMING GROWTH FACTOR BETA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVATION; FEMALE; FIBROGENESIS; FIBROSING ALVEOLITIS; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG CARCINOGENESIS; LUNG LAVAGE; LUNG NON SMALL CELL CANCER; LUNG PARENCHYMA; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REGULATOR GENE; TERC GENE; TERT GENE;

AGED; BRONCHOALVEOLAR LAVAGE FLUID; CARCINOGENESIS; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; LUNG; MALE; MIDDLE AGED; RNA; RNA, MESSENGER; TELOMERASE;

EID: 84892374676     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2753     Document Type: Article

References (36)

1. Raghu G: Idiopathic pulmonary fibrosis: guidelines for diagnosis and clinical management have advanced from consensus-based in 2000 to evidence-based in 2011. Eur Respir J 37: 743-746, 2011.
2. Wuyts WA, Agostini C, Antoniou K, et al: The pathogenesis of pulmonary fibrosis: a moving target. Eur Respir J 41: 1207-1218, 2013.
3. Calado RT and Young NS: Telomere diseases. N Engl J Med 361: 2353-2365, 2009.
4. Vancheri C, Failla M, Crimi N and Raghu G: Idiopathic pulmonary fibrosis: a disease with similarities and links to cancer biology. Eur Respir J 35: 496-504, 2010.
5. Vancheri C and Du Bois RM: A progression-free end-point for idiopathic pulmonary fibrosis trials: lessons from cancer. Eur Respir J 41: 262-269, 2013.
6. Vancheri C: Idiopathic pulmonary fibrosis: an altered fibroblast proliferation linked to cancer biology. Proc Am Thorac Soc 9: 153-157, 2012.
7. Collins K and Mitchell JR: Telomerase in the human organism. Oncogene 21: 564-579, 2002.
8. Fernandez-Garcia I, Ortiz-de-Solorzano C and Montuenga LM: Telomeres and telomerase in lung cancer. J Thorac Oncol 3: 1085-1088, 2008.
9. Broccoli D, Young JW and De Lange T: Telomerase activity in normal and malignant hematopoietic cells. Proc Natl Acad Sci USA 92: 9082-9086, 1995.
10. Wright WE, Piatyszek MA, Rainey WE, Byrd W and Shay JW: Telomerase activity in human germline and embryonic tissues and cells. Dev Genet 18: 173-179, 1996.
11. Kim NW, Piatyszek MA, Prowse KR, et al: Specific association of human telomerase activity with immortal cells and cancer. Science 266: 2011-2015, 1994.
12. Diaz de Leon A, Cronkhite JT, Katzenstein AL, et al: Telomere lengths, pulmonary fibrosis and telomerase (TERT) mutations. PLoS One 5: e10680, 2010.
13. American Thoracic Society: Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS) and the European Respiratory Society (ERS). Am J Respir Crit Care Med 161: 646-664, 2000.
14. Margaritopoulos GA, Antoniou KM, Soufla G, Vassalou E, Spandidos DA and Siafakas NM: Yin Yang-1 (YY-1) expression in idiopathic pulmonary fibrosis. J Recept Signal Transduct Res 31: 188-191, 2011.
15. Mehrad B, Burdick MD, Zisman DA, et al: Circulating peripheral blood fibrocytes in human fibrotic interstitial lung disease. Biochem Biophys Res Commun 353: 104-108, 2007.
16. Samara KD, Antoniou KM, Karagiannis K, et al: Expression profiles of Toll-like receptors in non-small cell lung cancer and idiopathic pulmonary fibrosis. Int J Oncol 40: 1397-1404, 2012.
17. Antoniou KM, Soufla G, Proklou A, et al: Different activity of the biological axis VEGF-Flt-1 (fms-like tyrosine kinase 1) and CXC chemokines between pulmonary sarcoidosis and idiopathic pulmonary fibrosis: a bronchoalveolar lavage study. Clin Dev Immunol 2009: 537929, 2009.
18. Margaritopoulos GA, Antoniou KM, Karagiannis K, et al: Investigation of Toll-like receptors in the pathogenesis of fibrotic and granulomatous disorders: a bronchoalveolar lavage study. Fibrogenesis Tissue Repair 3: 20, 2010.
19. Antoniou KM, Soufla G, Lymbouridou R, et al: Expression analysis of angiogenic growth factors and biological axis CXCL12/CXCR4 axis in idiopathic pulmonary fibrosis. Connect Tissue Res 51: 71-80, 2010.
20. Margaritopoulos GA, Romagnoli M, Poletti V, Siafakas NM, Wells AU and Antoniou KM: Recent advances in the pathogenesis and clinical evaluation of pulmonary fibrosis. Eur Respir Rev 21: 48-56, 2012.
21. Lasithiotaki I, Antoniou KM, Derdas SP, et al: The presence of merkel cell polyomavirus is associated with deregulated expression of BRAF and Bcl-2 genes in non-small cell lung cancer. Int J Cancer 133: 604-611, 2013.
22. Lasithiotaki I, Antoniou KM, Vlahava VM, et al: Detection of herpes simplex virus type-1 in patients with fibrotic lung diseases. PLoS One 6: e27800, 2011.
23. Antoniou KM, Margaritopoulos GA, Soufla G, et al: Expression analysis of Akt and MAPK signaling pathways in lung tissue of patients with idiopathic pulmonary fibrosis (IPF). J Recept Signal Transduct Res 30: 262-269, 2010.
24. Wang Y, Kuan PJ, Xing C, et al: Genetic defects in surfactant protein A2 are associated with pulmonary fibrosis and lung cancer. Am J Hum Genet 84: 52-59, 2009.
25. Tsakiri KD, Cronkhite JT, Kuan PJ, et al: Adult-onset pulmonary fibrosis caused by mutations in telomerase. Proc Natl Acad Sci USA 104: 7552-7557, 2007.
26. Diaz de Leon A, Cronkhite JT, Yilmaz C, et al: Subclinical lung disease, macrocytosis, and premature graying in kindreds with telomerase (TERT) mutations. Chest 140: 753-763, 2011.
27. Flores I, Benetti R and Blasco MA: Telomerase regulation and stem cell behaviour. Curr Opin Cell Biol 18: 254-260, 2006.
28. Lin SY and Elledge SJ: Multiple tumour suppressor pathways negatively regulate telomerase. Cell 113: 881-889, 2003.
29. Alder JK, Chen JJ, Lancaster L, et al: Short telomeres are a risk factor for idiopathic pulmonary fibrosis. Proc Natl Acad Sci USA 105: 13051-13056, 2008.
30. Meyer KC, Raghu G, Baughman RP, et al; for the American Thoracic Society Committee on BAL in Interstitial Lung Disease: An official American Thoracic Society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease. Am J Respir Crit Care Med 185: 1004-1014, 2012.
31. Antoniou KM, Margaritopoulos GA, Proklou A, et al: Investigation of telomerase/telomeres system in bone marrow mesenchymal stem cells derived from IPF and RA-UIP. J Inflamm (Lond) 9: 27, 2012.
32. Liu Z, Li Q, Li K, et al: Telomerase reverse transcriptase promotes epithelial-mesenchymal transition and stem cell-like traits in cancer cells. Oncogene 32: 4203-4213, 2012.
33. Samara KD, Tzortzaki EG, Neofytou E, et al: Somatic DNA alterations in lung epithelial barrier cells in COPD patients. Pulm Pharmacol Ther 23: 208-214, 2010.
34. Cronkhite JT, Xing C, Raghu G, et al: Telomere shortening in familial and sporadic pulmonary fibrosis. Am J Respir Crit Care Med 178: 729-737, 2008.
35. Antoniou KM, Papadaki HA, Soufla G and Siafakas NM: Short telomeres and treatment of pulmonary fibrosis: implications for early intervention. Am J Respir Crit Care Med 179: 970, 2009.
36. Garcia CK: Idiopathic pulmonary fibrosis: update on genetic discoveries. Proc Am Thorac Soc 8: 158-162, 2011.